From National Institute on Drug Abuse (NIDA) News Releases:
NIH study in rodents identifies a pathway that starts with glutamate and ends with activation of dopamine reward system
November 12, 2014
Details of the role of glutamate, the brain’s excitatory chemical, in a drug reward pathway have been identified for the first time.
This discovery in rodents – published today in Nature Communications – shows that stimulation of glutamate neurons in a specific brain region (the dorsal raphe nucleus) leads to activation of dopamine-containing neurons in the brain’s reward circuit (dopamine reward system).
Dopamine is a neurotransmitter present in regions of the brain that regulate movement, emotion, motivation, and feelings of pleasure. Glutamate is a neurotransmitter whose receptors are important for neural communication, memory formation, and learning. The research was conducted at the Intramural Research Program (IRP) of the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health.The research focused on the dorsal raphe nucleus, which has long been a brain region of interest to drug abuse researchers, since nerve cells in this area connect to part of the dopamine reward system. Many of the pathways are rich in serotonin, a neurotransmitter linked to mood regulation. Even though electrical stimulation of the dorsal raphe nucleus promotes reward-related behaviors, drugs that increase serotonin have low abuse potential. As a result, this region of the brain has always presented a seeming contradiction, since it is involved in drug reward but is also abundant in serotonin – a chemical not known for a role in drug reinforcement. This has led researchers to theorize that another neurotransmitter may be responsible for the role that the dorsal raphe nucleus plays in reward.
“We now have strong evidence of a reward pathway that starts with stimulation of glutamate neurons in the dorsal raphe nucleus and ends in activation of the dopamine reward system,” said NIDA Director Dr. Nora D. Volkow. “These findings help us better understand the brain’s reward circuitry and opens up new avenues of research into the neurobiology of drug addiction.”
In these rodent models, researchers used special tracers and labelling compounds to confirm that this circuit in the reward pathway begins with glutamate cells in the dorsal raphe nucleus that connect to dopamine cells in the ventral tegmental area, which in turn travel to the nucleus accumbens, a brain structure linked to motivation, pleasure, and reward. After verifying the pathway, investigators used optogenetic techniques (using light to control activity of modified cells) and chemical blockers to confirm that glutamate, not serotonin, is responsible for activating this reward circuitry.